Pulmonx
LUNG· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -67.5% in FY2025
Glendon E. French is the CEO of Pulmonx and was paid $3.5M in FY2025 (Dec), up 971%.
Pay$100 in the stock at the end of FY21 → $7
Executives5
See all- 1Steven S. WilliamsonFormer Chief Executive OfficerFY2024
- 2Glendon E. FrenchChief Executive OfficerFY2025
- 3Derrick Sung, Ph.DChief Operating Officer and Chief Financial OfficerFY2025
- 4Mehul JoshiFormer Chief Financial OfficerFY2025
- 5David LehmanGeneral CounselFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allPulmonx paid its 4 named executives $10.2M in total in FY2025 (Dec). CEO Glendon E. French was paid $3.5M of that.
| Name | |||
|---|---|---|---|
| Glendon E. FrenchChief Executive Officer | |||
| Derrick Sung, Ph.DChief Operating Officer and Chief Financial Officer | |||
| Mehul JoshiFormer Chief Financial Officer | |||
| David LehmanGeneral Counsel | |||
| Steven S. WilliamsonFormer Chief Executive Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board5
See all- Dana G. MeadChair · 15 yr on the boardIndependentAudit—Paid as an executive
- Richard M. FerrariDirector · 18 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
- Daniel P. FlorinDirector · 5 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive
- Thomas W. BurnsDirector · 5 yr on the boardIndependentCompensation—Paid as an executive
- Tiffany SullivanDirector · 4 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 22, 2026 | FY2025 |
| Annual report | 10-K | Mar 10, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 8, 2025 | FY2024 |
| Annual report | 10-K | Feb 25, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 5, 2024 | FY2023 |
| Annual report | 10-K | Feb 27, 2024 | FY2023 |